Since IGFBP-3 sequesters IGF-I from circulation (Lee and Rechler, 1996), the decreased levels of IGFBP-3 that result from the translocation may increase the bioavailability of IGF-I, thus promoting tumor growth (Kim et al., 2009). This evidence concerns the gene IGF1 and neoplasm.